Detalles de la búsqueda
1.
Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 36(3): 305-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24997825
2.
Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer.
Chin J Cancer Res
; 25(2): 200-5, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592901
3.
[Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status].
Zhonghua Zhong Liu Za Zhi
; 34(10): 780-4, 2012 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-23291074
4.
[Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer].
Zhonghua Yi Xue Za Zhi
; 92(22): 1527-31, 2012 Jun 12.
Artículo
en Zh
| MEDLINE | ID: mdl-22944054
5.
[Association of serum EGFR protein concentration with the efficacy of Gefitinib in the treatment of advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 33(6): 431-5, 2011 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-21875483
6.
[Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 33(2): 142-6, 2011 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-21575486
7.
[Factors affecting the sensitivity of EGFR-TKI treatment in advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 33(3): 217-21, 2011 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-21575523
8.
[Analysis of chemotherapeutic efficacy after a failed regimen of epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced non-small cell lung carcinoma].
Zhonghua Yi Xue Za Zhi
; 91(6): 366-9, 2011 Feb 15.
Artículo
en Zh
| MEDLINE | ID: mdl-21418906
9.
[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy].
Zhonghua Zhong Liu Za Zhi
; 30(6): 465-8, 2008 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19024525
10.
[Sequential administration of gefitinib and docetaxel as second-line therapy for advanced non-small cell lung cancer: analysis of 82 cases].
Zhonghua Yi Xue Za Zhi
; 88(32): 2258-62, 2008 Aug 19.
Artículo
en Zh
| MEDLINE | ID: mdl-19087674
11.
[Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients].
Zhonghua Zhong Liu Za Zhi
; 29(4): 298-301, 2007 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-17760260
12.
[Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 29(7): 549-51, 2007 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-18069641
13.
[Combined modality therapy for small cell lung cancer patient with limited stage disease].
Zhonghua Zhong Liu Za Zhi
; 29(9): 701-3, 2007 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-18246803
14.
[Establishment of a model to assess the clinical efficacy of Gefitinib in treatment of non-small cell lung cancer].
Zhonghua Yi Xue Za Zhi
; 87(43): 3069-73, 2007 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-18261354
15.
[Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 28(10): 777-9, 2006 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-17366795
16.
[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 28(3): 196-9, 2006 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-16875604
17.
[Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].
Zhonghua Zhong Liu Za Zhi
; 28(2): 107-10, 2006 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-16750013
18.
[Docetaxel in the treatment of advanced breast cancer ].
Zhonghua Zhong Liu Za Zhi
; 28(6): 468-70, 2006 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-17152498
19.
[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 28(4): 309-12, 2006 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-16875636
20.
Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma.
Thorac Cancer
; 7(2): 222-5, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042225